{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:18:57Z","timestamp":1785442737125,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-5067-1","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T05:02:50Z","timestamp":1543208570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET\/CT in advanced epithelial ovarian cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"In Ok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ji","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-1052","authenticated-orcid":false,"given":"Young Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"5067_CR1","doi-asserted-by":"crossref","unstructured":"Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev. 2011;(8):Cd007565.","DOI":"10.1002\/14651858.CD007565.pub2"},{"key":"5067_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). In Network NCC, editor. Ovarian Cancer including Fallopian Tube Cancer and Primary Peritoneal Cancer; 2016."},{"issue":"1","key":"5067_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","volume":"114","author":"DS Chi","year":"2009","unstructured":"Chi DS, Eisenhauer EL, Zivanovic O, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114(1):26\u201331.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"5067_CR4","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3802\/jgo.2015.26.4.336","volume":"26","author":"S-J Chang","year":"2015","unstructured":"Chang S-J, Bristow RE, Chi DS, Cliby WA. Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol. 2015;26(4):336\u201342.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"5067_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ygyno.2009.10.059","volume":"116","author":"EJ Nam","year":"2010","unstructured":"Nam EJ, Yun MJ, Oh YT, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET\/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010;116(3):389\u201394.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"5067_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","volume":"28","author":"P Castellucci","year":"2007","unstructured":"Castellucci P, Perrone AM, Picchio M, et al. Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun. 2007;28(8):589\u201395.","journal-title":"Nucl Med Commun"},{"key":"5067_CR7","first-page":"207","volume-title":"SURGERY for OVARIAN CANCER","author":"C Fotopoulou","year":"2015","unstructured":"Fotopoulou C. Cytoreductive surgery: abdominal retroperitoneum and adenopathy. In: Bristow RE, Karlan BY, Chi DS, editors. SURGERY for OVARIAN CANCER. Third ed. Boca Raton, FL: CRC Press; 2015. p. 207.","edition":"Third ed"},{"issue":"3","key":"5067_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.ygyno.2013.09.024","volume":"131","author":"R Fruscio","year":"2013","unstructured":"Fruscio R, Sina F, Dolci C, et al. Preoperative 18F-FDG PET\/CT in the management of advanced epithelial ovarian cancer. Gynecol Oncol. 2013;131(3):689\u201393.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5067_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2013.07.093","volume":"131","author":"T Perri","year":"2013","unstructured":"Perri T, Ben-Baruch G, Kalfon S, et al. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction? Gynecol Oncol. 2013;131(1):27\u201331.","journal-title":"Gynecol Oncol"},{"key":"5067_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ajog.2008.06.052","volume":"199","author":"A Fagotti","year":"2008","unstructured":"Fagotti A, Ferrandina G, Fanfani F, et al. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol. 2008;199:642\u20136 e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"5067_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0009-9260(97)80034-7","volume":"52","author":"BJ Holloway","year":"1997","unstructured":"Holloway BJ, Gore ME, A'Hern RP, Parsons C. The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol. 1997;52(9):692\u20137.","journal-title":"Clin Radiol"},{"issue":"6","key":"5067_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/IGC.0b013e3181e833f5","volume":"20","author":"V Kolev","year":"2010","unstructured":"Kolev V, Mironov S, Mironov O, et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20(6):979\u201384.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"5067_CR13","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1245\/s10434-015-5015-0","volume":"23","author":"TH Kim","year":"2016","unstructured":"Kim TH, Lim MC, Kim SI, Seo SS, Kim SH, Park SY. Preoperative prediction of Cardiophrenic lymph node metastasis in advanced ovarian Cancer using computed tomography. Ann Surg Oncol. 2016;23(4):1302\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"5067_CR14","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1378\/chest.111.6.1718","volume":"111","author":"CF Mountain","year":"1997","unstructured":"Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111(6):1718\u201323.","journal-title":"Chest"},{"key":"5067_CR15","volume-title":"Anatomie des lymphatics de l\u2019Homme","author":"H Rouvier","year":"1935","unstructured":"Rouvier H. Anatomie des lymphatics de l\u2019Homme. Paris: Masson; 1935."},{"key":"5067_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fonc.2013.00260","volume":"3","author":"S Farmakis","year":"2013","unstructured":"Farmakis S, Vejdani K, Muzaffar R, Parkar N, Osman MM. Detection of metastatic disease in Cardiophrenic lymph nodes: FDG PET\/CT versus contrast-enhanced CT and implications for staging and treatment of disease. Front Oncol. 2013;3:260.","journal-title":"Front Oncol"},{"issue":"1","key":"5067_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","volume":"126","author":"J Hynninen","year":"2012","unstructured":"Hynninen J, Auranen A, Carpen O, et al. FDG PET\/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. Gynecol Oncol. 2012;126(1):64\u20138.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5067_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygyno.2015.05.007","volume":"138","author":"O Raban","year":"2015","unstructured":"Raban O, Peled Y, Krissi H, et al. The significance of paracardiac lymph-node enlargement in patients with newly diagnosed stage IIIC ovarian cancer. Gynecol Oncol. 2015;138(2):259\u201362.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5067_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.ygyno.2006.10.010","volume":"104","author":"MM Juretzka","year":"2007","unstructured":"Juretzka MM, Abu-Rustum NR, Sonoda Y, et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecol Oncol. 2007;104(3):670\u20134.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"5067_CR20","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1245\/s10434-009-0486-5","volume":"16","author":"MC Lim","year":"2009","unstructured":"Lim MC, Lee HS, Jung DC, Choi JY, Seo SS, Park SY. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol. 2009;16(7):1990\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5067_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygyno.2012.12.023","volume":"129","author":"HJ Yoo","year":"2013","unstructured":"Yoo HJ, Lim MC, Song YJ, et al. Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer. Gynecol Oncol. 2013;129(2):341\u20135.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5067_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ygyno.2016.03.012","volume":"141","author":"S Prader","year":"2016","unstructured":"Prader S, Harter P, Grimm C, et al. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer. Gynecol Oncol. 2016;141(2):271\u20135.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-5067-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-5067-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:09:34Z","timestamp":1574708974000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-5067-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["5067"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-5067-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of Yonsei University College of Medicine, which waived the requirement for informed consent based on the study design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1165"}}